A pilot study to compare the effect of oestrogen combined with a progestogen in the form of either an oral contraceptive (OC) or hormone replacement therapy (HRT) on bone mineral density (BMD) in normogonadotropic hypoestrogenic anovulatory women.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Feb 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Estradiol/dydrogesterone (Primary) ; Ethinylestradiol/levonorgestrel (Primary) ; Estradiol
Indications Hypogonadism; Osteoporosis
Focus Therapeutic Use

Most Recent Events

30 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
03 Sep 2012 Planned End Date changed to 30 Sep 2012.
21 Oct 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight